Mitotherapeutix develops siRNA-based drugs that focus on addressing difficult disease targets.

Biotechnology

Health Care

Research

Mitotherapeutix

Mitotherapeutix's headquarters in Farmington, CT, United States

Jack Talley

Cynthia Arbeeny

Patrick Shao

Robert Hemley

Geoffrey White

Fenel Eloi

Dan Wagner

David Meeker

Wajahat Zafar Mehal

Richard Gregory

Robert Hennessey

Frank Marco

Gerald Shadel

James Digregori

Maria Martinez-Chantar

Mercedes Rincon

The Scientific Advisory Team at Mitotherapeutix provides expert guidance on the development of siRNA-based drugs, offering insights on scientific feasibility, latest research advancements, and strategic direction to effectively address challenging disease targets.

Scientific Advisory Team

The Leadership Team at Mitotherapeutix is responsible for setting the strategic direction of the company, guiding the development of siRNA-based therapeutics, and making high-level decisions to drive innovation in addressing challenging disease targets. Comprising seasoned executives and co-founders, the team collaborates to align operational goals, oversee research and development efforts, and ensure the company's vision is realized effectively within the biopharmaceutical landscape.

Leadership Team

The Advisory and Oversight team at Mitotherapeutix consists of board members and specialized advisors who provide strategic guidance, assess business risks, and ensure regulatory compliance. Their collective expertise helps in making informed decisions regarding the development and commercialization of siRNA-based drugs.

Advisory and Oversight

Mitotherapeutix

Org chart

Board & advisors

Teams

Scientific Advisory Team

Leadership Team

Advisory and Oversight

Offices

Mitotherapeutix

Org chart

Board & advisors

Teams

Scientific Advisory Team

Leadership Team

Advisory and Oversight

Offices

Related companies